Publications

12 Jun 2020
News

What Blockchain Could Mean for Your Health Data

September 2023
Teaching Note

Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment

By: Regina E. Herzlinger

Teaching Note for HBS Case No. 304-009. The case is part of the first module of the Innovating in Health Care course. Its purpose is to demonstrate how to evaluate the “do good” and do well” potential of a health care innovation. View Details

Keywords: Innovation In Healthcare Delivery; Innovation; Obesity; Digital Health; Weight Loss; Health Care and Treatment; Innovation and Management; Business Model; Medical Specialties; Mission and Purpose; Health Industry

Research Summary

Overview

Phil's work aims to identify the drivers of performance for healthcare organizations and providers, and the mechanisms by which this performance can change over time. In complex healthcare settings, the optimal choice of treatment can be highly ambiguous. As a... View Details

Keywords: Primary Care; Medical Decision-making; Learning By Doing; Healthcare Organizations; Healthcare Operations; Health Economics

May 2017
Teaching Plan

Neurotrack and the Alzheimer's Puzzle

By: Richard G. Hamermesh and Carin-Isabel Knoop

Teaching Note for HBS No. 816-072. View Details

Keywords: Health Care; Alzheimer's Disease; Career Path; Life Science Business

August 14, 2020
Comment

How Has COVID-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey

By: Leemore S. Dafny, Yin Wei Soon, Zoë Cullen and Christopher T. Stanton

As the COVID-19 pandemic stretches toward its third quarter, loss of health insurance coverage has not figured prominently in the public debate. Data in this report demonstrate why that is, but also suggest that the apparent stability is fragile, with potentially... View Details

Keywords: Health Pandemics; Health Care and Treatment; Insurance; Small Business; Surveys; United States

Find at Harvard

Register to Read

Research Summary

Clinical Trials as a setting for Health Policy and Management Research

The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details

November 2016
Case

QuintilesIMS: Biosimilar Marketing in England

By: John A. Quelch and Emily C. Boudreau

QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details

Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England

May 2024
Article

Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms

By: Caroline Marra and Ariel D. Stern

Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting... View Details

Keywords: Health Care and Treatment; Technological Innovation; Product Development; Health Testing and Trials; Governing Rules, Regulations, and Reforms

Read Now

16 May 2017
Blog Post

Making the Move into Digital Health and Software Engineering

We caught up with Andrea Coravos (HBS 2017) after a Q&A she did with the MBA Voices blog during her second year at HBS. Coravos reflects on her time at HBS and how she transitioned into digital health and engineering following a... View Details

Keywords: Health Care; Health Care

2006
Case

In Reach Care of the Elderly: Moss Valley Medical Practice

By: Julie Battilana, A. M. Cagna and T. D'Aunno

Keywords: Health Care and Treatment; Age

October 2017 (Revised April 2018)
Case

Improving Worker Safety in the Era of Machine Learning (A)

By: Michael W. Toffel, Dan Levy, Jose Ramon Morales Arilla and Matthew S. Johnson

Managers make predictions all the time: How fast will my markets grow? How much inventory do I need? How intensively should I monitor my suppliers? Which potential customers will be most responsive to a particular marketing campaign? Which job candidates should I... View Details

Keywords: Machine Learning; Policy Implementation; Empirical Research; Inspection; Occupational Safety; Occupational Health; Regulation; Analysis; Forecasting and Prediction; Policy; Operations; Supply Chain Management; Safety; Manufacturing Industry; Construction Industry; United States

September 2014 (Revised February 2015)
Case

Pfizer and AstraZeneca: Marketing an Acquisition (A)

By: John A. Quelch and James Weber

In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to... View Details

Keywords: Health Care Policy; Mergers And Acquisitions; Marketing; Government Relations; Crisis Management; Decision Making; Growth and Development; Management; Markets; Strategy; Pharmaceutical Industry; United Kingdom; United States

09 Sep 2014
News

If Your Kids Get Free Health Care, You’re More Likely to Start a Company

December 2013 (Revised May 2021)
Case

Paul Levy: Confronting a 'Corporate Campaign' (A)

By: James K. Sebenius

Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a... View Details

Keywords: Dispute Resolution; Corporate Campaign; Negotiating Campaign; Bargaining; Health Care; Hospitals; Unions; Health Care and Treatment; Negotiation; Strategy; Negotiation Process; Labor Unions; Health Industry; Boston

February 2017 (Revised February 2021)
Case

Hebrew SeniorLife: Next Steps

By: Regina E. Herzlinger, Carin-Isabel Knoop and Olivia Hull

The CEO of Hebrew SeniorLife is contemplating how to scale his highly successful but asset-intensive continuing care retirement community for elders. Among the strategies he is considering is an expansion to China; virtual web-based care; providing continuing care in... View Details

Keywords: Continuing Care; Nursing Home; Rehabilitation; Assisted Living; Elder Care; Entrepreneurial Management; Health Care and Treatment; Entrepreneurship; Growth and Development Strategy; Health Industry; United States

June 2024
Article

Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices

By: Jason Shafrin, Jaehong Kim, Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington and Richard Willke

This study argues that value assessment conducted from a societal perspective should rely on the Generalized Cost-Effectiveness Analysis (GCEA) framework proposed herein. Recently developed value assessment inventories—such as the Second Panel on Cost-Effectiveness’s... View Details

Keywords: Health Care and Treatment; Valuation; Cost vs Benefits; Society